Delivery Order SPE2DB22D1202-SPE2DB25FUZX1
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a ceiling value of $4,528.40 and runs through February 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract has a ceiling value of $1,314.20 and a completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a ceiling value of $2,145.24 and a period of performance through February 14, 2025. The contract is a firm fixed-price delivery order, and does not have a set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The contract is a firm fixed-price delivery order with a ceiling value of $2,908.44 and a period of performance through March 6, 2025. The award is not associated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a ceiling value of $1,398.84 and a performance period ending on January 29, 2025. This award is not associated with a set-aside program. AmerisourceBergen also holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, with a ceiling value of $1,270.30 and a completion date of March 21, 2024, is for the supply of Quillivant XR 25 mg/5 ml suspension medication. The contract is part of AmerisourceBergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The delivery order, valued at $6,340.16, has a firm fixed price and a performance period through July 18, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml oral suspension in 60 ml bottles. The contract has a firm fixed price of $1,524.36 and a completion date of September 11, 2024. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $1,359.75 and a period of performance through November 14, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
This is a $5,021.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The order has an ultimate completion date of March 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...